Device Debut: Medtronic Pulls Riptide Into Growing Stroke Offering

31 Jan 2018

Riptide complements Medtronic's Solitaire stent retriever revascularization device for the treatment of acute ischemic stroke. The company began rolling out Riptide at this year's International Stroke Conference, which also featured the presentation of important clinical data supporting aspiration as a first-line therapy for stroke.

Medtronic PLC unveiled a limited US market launch of its Riptide aspiration system for the treatment of ischemic stroke at the International Stroke Conference in Los Angeles, Jan. 24-26.

The company announced that US FDA cleared Riptide on Jan 16. According to FDA's 510(k) document, it is...